Aeglea’s Acquisition of Spyre

Leila Ahmed
Tagged:

Gibson, Dunn & Crutcher LLP is advising Spyre Therapeutics, Inc. in the transaction, while Cooley LLPis advising Aeglea.Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), announced it has completed the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now